Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trialFaizah Alotaibi, Hanan H. Balkhy, Majed Al Jeraisy et al.|Influenza and Other Respiratory Viruses|2023Cited by 52
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
Early immune events during SARS-CoV-2 infection impact memory T and B cell responsesKyra Woloszczuk, Scott Presnell, David Joyner et al.|Communications Biology|2026Cited by 0